Tirzepatide 15mg
Tirzepatide is a dual GIP/GLP-1 receptor agonist that has set new benchmarks in metabolic and weight loss research. As the compound behind some of the most significant findings in obesity science, tirzepatide demonstrates powerful effects on appetite regulation, glucose metabolism, and adipose tissue reduction. This 15mg vial provides researchers with an ample supply for comprehensive study protocols. Third-party HPLC tested. Lyophilised powder, requires reconstitution with bacteriostatic water.
Out of stock
This product is currently out of stock. Enter your email to be notified when it's back.
Crypto payments only — How to pay guide
Documentation
COA-backed
Source
Manufacturer COA
Shipping
Australia-wide
Payment
Crypto only
Research Guides
Tirzepatide Australia 2026: Research Guide, SURMOUNT Trial Data & Reconstitution
15 min read
Tirzepatide Weight Loss: A Deep Dive into SURMOUNT Trial Data
8 min read
Tirzepatide Dosing Protocol: SURMOUNT Trial Reference for Researchers
7 min read
Tirzepatide Australia 2026: Research Guide, SURMOUNT Data & Sourcing
9 min read